Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2003
10/30/2003WO2003088922A2 E7 regulation of p21cip1 through akt
10/30/2003WO2003088919A2 Compositions and methods for diagnostics and therapeutics for hydrocephalus
10/30/2003WO2003088913A2 Peptide deformylase activated prodrugs
10/30/2003WO2003088910A2 Methods of assaying for cell cycle modulators
10/30/2003WO2003088904A2 Screening and therapeutic methods for treating circadian rhythm disorders
10/30/2003WO2003088814A2 Systemic marker for monitoring anti-inflammatory and antioxidant actions of therapeutic agents
10/30/2003WO2003066579A3 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
10/30/2003WO2003060146A3 Compositions and methods relating to urinary specific genes and proteins
10/30/2003WO2003057919A3 The use of histamine h4 receptor antagonist for the treatment of inflammatory response
10/30/2003WO2003055989A3 Cellular compositions and methods of making and using them
10/30/2003WO2003054224A3 Method and integrated device for the detection of cytosine methylations
10/30/2003WO2003052420A3 Device and bioanalytical method utilizing asymmetric biofunction alized membrane
10/30/2003WO2003052142A3 Analysis and detection of multiple target sequences using circular probes
10/30/2003WO2003051388A3 Pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases
10/30/2003WO2003050233A3 Gene promoters
10/30/2003WO2003048340A3 Crystal structure of mitogen-activated protein kinase-activated protein kinase 2 and binding pockets thereof
10/30/2003WO2003047421A3 Methods and reagents for diagnosis and treatment of diabetes
10/30/2003WO2003046579A3 Cyp46 genotype determination for risk and treatment evaluation of alzheimer's disease
10/30/2003WO2003044481A3 Optical bio-discs and microfluidic devices for analysis of cells
10/30/2003WO2003038434A3 Serological assay for neospora caninum
10/30/2003WO2003038053A3 Reca assisted detection of mutations, single nucleotide polymorphisms and specific sequences
10/30/2003WO2003038045A3 Acid phosphatase (acp1) gene as a susceptibility locus for hyperlipidemia
10/30/2003WO2003036300A3 Diagnosis of cervical cancer
10/30/2003WO2003035693A3 Crystals of cytochrome p450 2c9, structures thereof and their use
10/30/2003WO2003034903A3 Psma antibodies and protein multimers
10/30/2003WO2003034061A3 System for the detection of urease and method for using same
10/30/2003WO2003034031A3 Highly sensitive methods for protein detection in proteomics
10/30/2003WO2003031648A3 Method for detecting dna methylation using labelled s-adenosylmethionine analogs
10/30/2003WO2003031612A3 Method for determining cell cycle position
10/30/2003WO2003031568A3 Intracellular signaling molecules
10/30/2003WO2003029482A3 Diagnosing, treating, and preventing cancer using cables
10/30/2003WO2003029480A3 Measurements of multiple molecules using a cryoarray
10/30/2003WO2003029428A3 Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease
10/30/2003WO2003027311A3 A clone-array pooled shotgun strategy for nucleic acid sequencing
10/30/2003WO2003027143A3 Gene and protein relating to hepatocellular carcinoma
10/30/2003WO2003025199A3 Mid 4460, a human tyrosine phosphatase family member and uses therefor
10/30/2003WO2003020976A3 Oligonucleotides for use in detection of human papillomavirus e7 mrna
10/30/2003WO2003020896A3 Production of cultured human mast cells and basophils for high throughput small molecule drug discovery
10/30/2003WO2003020287A3 Methods for the treatment of chronic pain anc compositions therefor
10/30/2003WO2003018836A3 Model of autoimmune disease and methods for identifying agents against autoimmune disease
10/30/2003WO2003016549A3 Nucleic-acid associated proteins
10/30/2003WO2003010335A3 Il-4 receptor sequence variation associated with type 1 diabetes
10/30/2003WO2003010333A3 Methods for gene disruption and uses thereof
10/30/2003WO2003008635A8 η-SECRETASE IN VITRO SCREENING ASSAY
10/30/2003WO2003004698A3 Method for monitoring and modulating protein folding
10/30/2003WO2003000917A3 Electrochemical detection of mismatch nucleic acids
10/30/2003WO2002103042A3 Method and nucleic acids for the differentiation of prostate tumors
10/30/2003WO2002102229A3 Diagnosing tumorigenicity and determining resistance to anticancer therapy
10/30/2003WO2002099041A3 Ces2s as modifiers of the p53 pathway and methods of use
10/30/2003WO2002097390A3 A quantitative hybridization assay for the analysis of nucleic acid
10/30/2003WO2002092858A3 Methods of screening for disease
10/30/2003WO2002084294A3 Gastrointestinal glutathione peroxidase in hepatitis c virus infections
10/30/2003WO2002083945A3 Diagnosis and treatment of cancer: i
10/30/2003WO2002083943A3 Microarray method for enriching dna fragments from complex mixtures
10/30/2003WO2002083882A3 Regulation of human serine/threonine protein kinase-like protein
10/30/2003WO2002080755A3 Kits and methods for assessing oxidative stress
10/30/2003WO2002073204A3 Cell-based detection and differentiation of disease states
10/30/2003WO2002073172A3 Determination of analytes by means of fluorescence correlation spectroscopy
10/30/2003WO2002072881A3 Method for the amplification and detection of hbv dna using a transcription based amplification
10/30/2003WO2002071060A3 Use of metabolic phenotyping in individualized treatment with amonafide
10/30/2003WO2002070741A3 Methods, systems and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the dna
10/30/2003WO2002068697A3 Methods for decreasing non-specific binding of beads in dual bead assays including related optical biodiscs and disc drive systems
10/30/2003WO2002068683A3 Circular probe amplification (cpa) using energy-transfer primers
10/30/2003WO2002068645A3 Compositions and methods relating to breast specific genes and proteins
10/30/2003WO2002068617A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/30/2003WO2002066637A8 Method for collecting and using nuclear mrna
10/30/2003WO2002064784A3 Yeast strain of saccharomyces cerevisiae with functional expression of a glut transporter
10/30/2003WO2002063030A3 Charge tags and separation of nucleic acid molecules
10/30/2003WO2002061430A3 Methods and reagents for treating autoimmune disorders
10/30/2003WO2002059327A3 Sulfatases and methods of use thereof
10/30/2003WO2002059283A3 Nucleic acid modification enzymes
10/30/2003WO2002056909A3 Method for inducing an immune response to polysaccharide bacterial antigens and to protein structures of virus capsids
10/30/2003WO2002053779A3 Cell-free assay and in vivo method for plant genetic repair using chloroplast lysate
10/30/2003WO2002044361A8 Eukaryotic expression libraries based on double lox recombination and methods of use
10/30/2003WO2002034783A3 Transmembrane proteins
10/30/2003WO2002027023A9 Genetic determinants for dermal inflammation and immunity
10/30/2003WO2002022819A3 Calcium binding proteins
10/30/2003WO2002018639A9 Detection of cyp2c19 polymorphisms
10/30/2003WO2002014858A3 Method for producing and identifying appropriate effectors of target molecules using substance libraries
10/30/2003WO2002012555A3 Means for targeting nucleic acid repeat regions
10/30/2003WO2002008447A3 Nucleic acids and methods for detecting viral infection, uncovering anti-viral drug candidates and determining drug resistance of viral isolates
10/30/2003WO2001094361A3 Haplotypes of the pcdh2 gene
10/30/2003WO2001090308A8 Method of determining thiopurine methyltransferase activity
10/30/2003WO2001090118A3 Haplotypes of the edn2 gene
10/30/2003WO2001085995A3 Identification of neural defects associated with the nucleosom al assembly protein 1l2 gene
10/30/2003US20030204861 Transgenic animal model for spliceosome-mediated RNA trans-splicing
10/30/2003US20030204331 Automated sample preparation methods and devices
10/30/2003US20030204322 High throughput assay; sold phase synthesis; drug screening
10/30/2003US20030204321 Efficient algorithm for PCR testing of blood samples
10/30/2003US20030204320 Neural-network-based identification, and application, of genomic information practically relevant to diverse biological and sociological problems, including susceptibility to disease
10/30/2003US20030204319 Neural-network-based identification, and application, of genomic information practically relevant to diverse biological and sociological problems, including identification of clinically relevant combinations of alleles and proteins
10/30/2003US20030204316 System for cell-based screening
10/30/2003US20030204075 A single nucleotide polymorphisms (SNP) probe consisting of an oligonudeotide that is complementary to a SNP nucleic acid
10/30/2003US20030204073 Identifying an allosteric modulator/antagonist of g-protein coupled receptors for treatment of metabolic disorders
10/30/2003US20030204072 Comprises receptor protein tyrosine kinase (rPTK) for diagnosing and treating kidney or neurodegenerative diseases
10/30/2003US20030204071 109 human secreted proteins
10/30/2003US20030204070 Polynucleotide encoding a novel methionine aminopeptidase, protease-39
10/30/2003US20030204069 Segments of the human gene for telomerase reverse transcriptase
10/30/2003US20030204065 Comprises peptidoglycan recognition protein (PGRP) for diagnosis and treatment of blood and tumor disorders
10/30/2003US20030204052 Comprises polypeptide for treatment and prevention of autoimmune, cancer, inflammatory, nervous system, cardiomyopathy and atherosclerotic disorders
1 ... 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 2035 2036 2037 2038 2039 2040 2041 2042 ... 3003